11.04 +0.04 (0.36%)
ISIS
Stock Details
Last Trade:11.04 Change:+0.04 (0.36%) Prev Close:11.00 Open: 11.16 Days Range:10.97 – 11.24 52 Week Range: 9.77 - 18.81 Volume:632219 P/E: N/AEPS:-0.07
View AllRecent Alerts 02/10/10
Recent Alert on 12/21/09 at 8:18am
Isis Pharmaceuticals (ISIS) To Receive $10M from OncoGenex (OGXI) and Teva (TEVA) OGX-011 Licensing Agreement
Isis Pharmaceuticals (ISIS) To Receive $10M from OncoGenex (OGXI) and Teva (TEVA) OGX-011 Licensing Agreement
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. (NASDAQ:... Read More
Recent Alert on 12/17/09 at 8:47am
Regulus Therapeutics Obtains microRNA Exclusive Rights (ALNY, ISIS)
Regulus Therapeutics Obtains microRNA Exclusive Rights (ALNY, ISIS)
Recent Alert on 12/15/09 at 8:23am
Isis Pharma (ISIS) and Alnylam Pharma (ALNY) Receive a Notice of Allowance from U.S. FDA for "Crooke" Patent Family
Isis Pharma (ISIS) and Alnylam Pharma (ALNY) Receive a Notice of Allowance from U.S. FDA for "Crooke" Patent Family
Recent Alert on 12/15/09 at 8:23am
Isis Pharma (ISIS) and Alnylam Pharma (ALNY) Receive a Notice of Allowance from U.S. FDA for "Crooke" Patent Family
Isis Pharma (ISIS) and Alnylam Pharma (ALNY) Receive a Notice of Allowance from U.S. FDA for "Crooke" Patent Family
Recent Alert on 12/04/09 at 7:27am
Isis Pharmaceuticals (ISIS) volatility elevated; shares near 30-month low
Isis Pharmaceuticals (ISIS) volatility elevated; shares near 30-month low
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 11/25/09 at 7:31am
Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate
Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate